Is Abbott Laboratories stock a ‘buy’ after market-beating Q2 results?

Abbott Laboratories (NYSE: ABT) down more than 20% for the year is an opportunity to buy a quality name at a deep discount, says Brenda Vingiello. She’s the Chief Investment Officer at Sand Hill Globa...

Macau Casinos Could Become Digital Yuan Laboratories

As Macau casinos bid for new licenses, Chinese regulators could use the leverage to introduce experimental implementations of the digital yuan. Current concessions in the $37 billion market are set to...